Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy

Transplantation

Volumn 62, Issue 5, 1996, Pages 547-552

  Nakakura, Eric K ^a,b   Shorthouse, Randi A ^a   Zheng, Biru ^a   Mccabe, Susan M ^c   Jardieu, Paula M ^c   Morris, Randall E ^a,d  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GENENTECH INC   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; IMMUNOGLOBULIN G2A; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029813191     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199609150-00001     Document Type: Article

References (39)

1. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425.
2. Heemann UW, Tullius SG, Azuma H, Kupiec-Weglinsky J, Tilney NL. Adhesion molecules and transplantation. Ann Surg 1994; 219: 4.
3. Krensky A, Sanchez-Madrid F, Robbins E, Nagy J, Springer T, Burakoff S. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol 1983; 131: 611.
4. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction of IL-1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245.
5. de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991; 174: 253.
6. de Fougerolles AR, Qin X, Springer TA. Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses. J Exp Med 1994; 179: 619.
7. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 1987; 5: 223.
8. Dustin ML, Springer TA. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 1988; 107: 321.
9. Benjamin R, Qin S, Wise M, Cobbold S, Waldmann H. Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA-1) molecules in self- non-self discrimination. Eur J Immunol 1988; 18: 1079.
10. Heagy W, Waltenbaugh C. Potent ability of anti-LFA-1 monoclonal antibody to prolong allograft survival. Transplantation 1984; 37: 520.
11. Fischer A, Friedrich W, Fasth A, et al. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiency: European Group for Bone Marrow Transplantation report. Blood 1991; 77: 249.
12. Morris RE. Mechanisms of action of new immunosuppressive drugs. Kidney Int 1996; 49 (suppl 53): S26.
13. Nakakura E, Jardieu P, Zheng B, Morris R. An anti-adhesion molecule (LFA-1, CD11a) monoclonal antibody suppresses ongoing rejection and prolongs heart allograft survival indefinitely without lymphocyte depletion [Abstract]. J Heart Lung Transplant 1992; 11: 223.
14. Nakakura EK, McCabe SM, Zheng B, et al. Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of nonprimarily vascularized heart allograft survival in mice without T cell depletion. Transplantation 1993; 55: 412.
15. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992; 255: 1125.
16. Stepkowski SM, Tu Y, Condon TP, Bennett CF. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J Immunol 1994; 153: 5336.
17. Kameoka H, Ishibashi M, Tamatani T, et al. The immunosuppressive action of anti-CD18 monoclonal antibody in rat heterotopic heart allotransplantation. Transplantation 1993; 55: 665.
18. Kameoka H, Ishibashi M, Tamatani T, et al. Comparative immunosuppressive effect of anti-CD18 and anti-CD11a monoclonal antibodies on rat heart allotransplantation. Transplant Proc 1993; 25: 833.
19. Komori A, Nagata M, Ochiai T, et al. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat. Transplant Proc 1993; 25: 831.
20. Paul LC, Davidoff A, Benediktsson H, Issekutz TB. The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection. Transplantation 1993; 55: 1196.
21. Morikawa M, Tamatani T, Miyasaka M, Uede T. Cardiac allografts in rat recipients with simultaneous use of antiICAM-1 and anti-LFA-1 monoclonal antibodies leads to accelerated graft loss. Immunopharmacology 1994; 28: 171.
22. Miwa S, Kawasaki S, Makuuchi M, et al. Role of ICAM-1 and LFA-1 in a cardiac xenograft rejection model. Transplant Proc 1995; 27: 111.
23. Harihara Y, Sakamoto H, Sanjo K, Otsubo O, Watanabe G, Idezuki Y. Prolongation of hepatic allograft survival with antibodies to ICAM-1 and LFA-1. Transplant Proc 1994; 26:2258.
24. Cosimi AB, Conti D, Delmonico FL, et al. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol 1990; 144: 4604.
25. Flavin T, Ivens K, Rothlein R, et al. Monoclonal antibodies against intercellular adhesion molecule 1 prolong cardiac allograft survival in cynomolgus monkeys. Transplant Proc 1991; 23: 533.
26. Hourmant M, Le Mauff B, Le Meur Y, et al. Administration of an anti-CD11a monoclonal antibody in recipients of kidney transplantation. A pilot study. Transplantation 1994; 58: 377.
27. Haug CE, Colvin RB, Delmonico FL, et al. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993; 55: 766.
28. Davignon D, Martz E, Reynolds T, Kurzinger K, Springer T. Monoclonal antibody to a novel lymphocyte function-associated antigen (LFA-1): mechanisms of blockade of T lymphocyte-mediated killing and effects on other T and B lymphocyte functions. J Immunol 1981; 127: 590.
29. Kanner SB, Grosmaire LS, Ledbetter JA, Damle NK. Beta 2-Integrin LFA-1 signaling through phospholipase C-gamma 1 activation. Proc Natl Acad Sci USA 1993; 90: 7099.
30. Yuh DY, Morris RE. The immunopharmacology of immunosuppression by 15-deoxyspergualin. Transplantation 1993; 55: 578.
31. MacDonald HR. Introduction: Mls - a retroviral superantigen. Semin Immunol 1992; 4: 285.
32. Herman A, Kappler JW, Marrack P, Pullen AM. Superantigens: mechanisms of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991; 9: 745.
33. Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 1990; 63: 1249.
34. + T lymphocytes on immunizing Mls-1b mice with Mis-la expressing cells. Nature 1989; 339: 541.
35. Le Mauff B, Hourmant M, Rougier J-P, et al. Effect of anti-LFA-1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation. Transplantation 1991; 52: 291.
36. a. Nature 1990; 345: 540.
37. Alters S, Shizuru J, Ackerman J, Grossman D, Seydel K, Fathman C. Anti-CD4 mediates clonal anergy during transplantation tolerance induction. J Exp Med 1991; 173: 491.
38. Jendrisak G, Gamero J, Mohanakumar T, Jendrisak M. Clonal anergy induction by monoclonal antibodies to CD4, LFA-1, and ICAM-1. Transplant Proc 1993; 25: 828.
39. Fischer A, Cavazzana-Calvo M, Jabado N, Sarnacki S. Monoclonal antibodies to adhesion molecules in bone marrow and organ transplantation. Austin, TX: RG Landes, 1995.